Skip to main content

Research Repository

Advanced Search

Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial

Mu, Rong; Bao, Chun de; Chen, Zhi wei; Zheng, Yi; Wang, Guo chun; Zhao, Dong bao; Hu, Shao xian; Li, Yu jun; Shao, Zeng wu; Zhang, Zhi yi; Xiao, Wei guo; Zhang, Weiya; Li, Zhan guo

Authors

Rong Mu

Chun de Bao

Zhi wei Chen

Yi Zheng

Guo chun Wang

Dong bao Zhao

Shao xian Hu

Yu jun Li

Zeng wu Shao

Zhi yi Zhang

Wei guo Xiao

Zhan guo Li



Abstract

© 2014, Clinical Rheumatology. This study is aimed at comparing the efficacy and safety of loxoprofen sodium hydrogel patch (LX-P) with loxoprofen sodium tablet (LX-T) in patients with knee osteoarthritis (OA). One hundred sixty-nine patients were enrolled in a randomized, controlled, double-blind, double-dummy, multicenter, non-inferiority trial of LX-P. Patients were randomly assigned to either LX-P or LX-T groups for a 4-week treatment. The primary efficacy endpoint was the proportion of patients with an overall improvement of ≥50 %, and the secondary efficacy endpoint was the proportion of patients with an improvement of ≥25 % from baseline in each of the seven main symptoms. The non-inferiority trial was based on a power of 80 % and significance level of 2.5 % with a non-inferiority margin of −10 %. In both intention-to-treat (ITT) and per-protocol (PP) analyses, LX-P was as effective as LX-T in regard to the primary endpoint. In the ITT analysis, the difference between the two groups was 12.6 % [95 % confidence interval, −1.7 to 26.9 %]. No significant differences were found between the two groups in any of the secondary efficacy outcomes. A lower incidence of adverse events was observed in LX-P group; however, the difference was not statistically significant. No serious adverse events were reported in the LX-P group, whereas one case was reported in LX-T group. Based on the present study, topical loxoprofen patch was non-inferior to oral loxoprofen in patients with knee osteoarthritis.

Journal Article Type Article
Acceptance Date May 25, 2014
Online Publication Date Jun 14, 2014
Publication Date Jan 1, 2016
Deposit Date Nov 26, 2019
Journal Clinical Rheumatology
Print ISSN 0770-3198
Electronic ISSN 1434-9949
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 35
Issue 1
Pages 165-173
DOI https://doi.org/10.1007/s10067-014-2701-4
Keywords Rheumatology; General Medicine
Public URL https://nottingham-repository.worktribe.com/output/3086465